Veeco Instruments Inc. - Q1 2005 10-Q Summary
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the three-month period ended March 31, 2005. Veeco Instruments Inc. designs, manufactures, and services equipment for the data storage, semiconductor, high brightness light emitting diode (HB-LED), and wireless telecommunications industries. The company operates through three segments: Ion Beam and Mechanical Process Equipment, Epitaxial Process Equipment, and Metrology.
Key Financial Metrics
| Metric | Q1 2005 | Q1 2004 |
|---|---|---|
| Net Sales | $93.9 million | $90.9 million |
| Gross Profit | $37.5 million (40.0% margin) | $36.8 million (40.5% margin) |
| Operating Loss | $(1.9) million | $(1.7) million |
| Net Loss | $(4.7) million | $(2.7) million |
| Net Loss Per Share | $(0.16) | $(0.09) |
| Cash from Operations | $14.4 million | $3.8 million |
| Cash and Equivalents (End of Period) | $100.7 million | $111.8 million |
| Total Debt | $229.8 million | N/A (Balance Sheet data) |
Note: Total debt consists of $0.4 million current portion and $229.5 million long-term debt as of March 31, 2005.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 3.3% year-over-year, driven by a 61.4% surge in Epitaxial Process Equipment sales and a 4.6% increase in Metrology sales. This was offset by a 21.2% decline in Ion Beam and Mechanical Process Equipment sales due to weakness in the data storage market.
- Profitability: Net loss widened to $4.7 million from $2.7 million in Q1 2004. Gross margin decreased slightly to 40.0% from 40.5%, impacted by warranty issues and pricing pressure in the MOCVD market.
- Cash Flow: Operating cash flow improved significantly to $14.4 million (from $3.8 million), primarily due to a $11.4 million reduction in accounts receivable and a $5.4 million reduction in inventory. However, investing activities consumed $14.7 million, largely due to $15.0 million in earn-out payments for prior acquisitions.
- Orders: Total orders decreased 15.5% to $98.9 million, with a book-to-bill ratio of 1.05.
Guidance, Outlook, and Risks
Outlook: Management expects higher revenues in data storage products and stability in metrology revenues for 2005, while anticipating lower revenues in epitaxial equipment. The company expects gross margins to improve sequentially throughout 2005 due to product mix changes and cost-cutting measures.
Accounting Investigation and Restatement: The company completed an internal investigation into improper accounting transactions at its TurboDisc business unit. This resulted in a restatement of 2004 financials, including a $10.2 million pre-tax adjustment. The investigation concluded the errors were made by a single terminated individual with no evidence of embezzlement.
Legal Proceedings: Following the announcement of the accounting issues, ten putative class action shareholder lawsuits and three shareholder derivative lawsuits have been filed. The company intends to defend these vigorously but notes they could result in substantial costs and diversion of management attention.
Stock-Based Compensation: The company plans to adopt SFAS No. 123(R) on January 1, 2006. To mitigate future expense, the Board accelerated the vesting of approximately 2.5 million out-of-the-money stock options in April 2005, avoiding an estimated $8.4 million in compensation expense in 2006.
Liquidity: The company maintains a $50.0 million revolving credit facility (no borrowings outstanding as of March 31, 2005) and believes existing cash and operations will meet requirements for the next 12 months.
Investor Verification Checklist
- Verify the status and potential financial impact of the pending securities class action and derivative lawsuits.
- Monitor the execution of the profitability improvement plan, specifically gross margin trends in the Epitaxial and Ion Beam segments.
- Assess the impact of the upcoming SFAS 123(R) adoption on future earnings, despite the acceleration of option vesting.
- Review the progress of the internal accounting investigation and any further restatements or regulatory inquiries.
- Track the realization of deferred tax assets, given the $54.0 million valuation allowance established in 2004.